Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury

Changes in the peroxisome proliferator-activated receptors-δ (PPARδ) expression in rats after spinal cord injury (SCI) have been previously reported. Diabetic animals show a higher mortality after SCI. However, the relationship between the progress of diabetes and PPARδ in SCI remains unknown. In th...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng-Chia Tsai, Kung-Shing Lee, Sheng-Hsien Chen, Li-Jen Chen, Keng-Fan Liu, Juei-Tang Cheng
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2014/456386
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545287333216256
author Cheng-Chia Tsai
Kung-Shing Lee
Sheng-Hsien Chen
Li-Jen Chen
Keng-Fan Liu
Juei-Tang Cheng
author_facet Cheng-Chia Tsai
Kung-Shing Lee
Sheng-Hsien Chen
Li-Jen Chen
Keng-Fan Liu
Juei-Tang Cheng
author_sort Cheng-Chia Tsai
collection DOAJ
description Changes in the peroxisome proliferator-activated receptors-δ (PPARδ) expression in rats after spinal cord injury (SCI) have been previously reported. Diabetic animals show a higher mortality after SCI. However, the relationship between the progress of diabetes and PPARδ in SCI remains unknown. In the present study, we used compressive SCI in streptozotocin-(STZ-) induced diabetic rats. GW0742, a PPARδ agonist, was used to evaluate its merit in STZ rats after SCI. Changes in PPARδ expression were detected by Western blot. Survival rates were also estimated. A lower expression of PPARδ in spinal cords of STZ-diabetic rats was observed. In addition, the survival times in two-week induction diabetes were longer than those in eight-week induction group, which is consistent with the expression of PPARδ in the spinal cord. Moreover, GW0742 significantly increased the survival time of STZ rats. Furthermore, their motor function and pain response were attenuated by GSK0660, a selective PPARδ antagonist, but were enhanced by GW0742. In conclusion, the data suggest that higher mortality rate in STZ-diabetic rats with SCI is associated with the decrease of PPARδ expression. Thus, change of PPARδ expression with the progress of diabetes seems responsible for the higher mortality rate after SCI.
format Article
id doaj-art-20f7b3748e234105a9fb9db6c2508e5b
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-20f7b3748e234105a9fb9db6c2508e5b2025-02-03T07:26:13ZengWileyPPAR Research1687-47571687-47652014-01-01201410.1155/2014/456386456386Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord InjuryCheng-Chia Tsai0Kung-Shing Lee1Sheng-Hsien Chen2Li-Jen Chen3Keng-Fan Liu4Juei-Tang Cheng5Department of Neurosurgery, Mackay Memorial Hospital, Taipei City 10449, TaiwanDepartment of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital and Kaohsiung Medical University, Kaohsiung City 81201, TaiwanDepartment of Obstetrics and Gynecology, Chi Mei Medical Center, Yong Kang, Tainan City 71101, TaiwanInstitute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan City 70101, TaiwanInstitute of Medical Science, College of Health Science, Chang Jung Christian University, Gui-Ren, Tainan City 71301, TaiwanDepartment of Medical Research, Chi Mei Medical Center, Yong Kang, Tainan City 71101, TaiwanChanges in the peroxisome proliferator-activated receptors-δ (PPARδ) expression in rats after spinal cord injury (SCI) have been previously reported. Diabetic animals show a higher mortality after SCI. However, the relationship between the progress of diabetes and PPARδ in SCI remains unknown. In the present study, we used compressive SCI in streptozotocin-(STZ-) induced diabetic rats. GW0742, a PPARδ agonist, was used to evaluate its merit in STZ rats after SCI. Changes in PPARδ expression were detected by Western blot. Survival rates were also estimated. A lower expression of PPARδ in spinal cords of STZ-diabetic rats was observed. In addition, the survival times in two-week induction diabetes were longer than those in eight-week induction group, which is consistent with the expression of PPARδ in the spinal cord. Moreover, GW0742 significantly increased the survival time of STZ rats. Furthermore, their motor function and pain response were attenuated by GSK0660, a selective PPARδ antagonist, but were enhanced by GW0742. In conclusion, the data suggest that higher mortality rate in STZ-diabetic rats with SCI is associated with the decrease of PPARδ expression. Thus, change of PPARδ expression with the progress of diabetes seems responsible for the higher mortality rate after SCI.http://dx.doi.org/10.1155/2014/456386
spellingShingle Cheng-Chia Tsai
Kung-Shing Lee
Sheng-Hsien Chen
Li-Jen Chen
Keng-Fan Liu
Juei-Tang Cheng
Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
PPAR Research
title Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
title_full Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
title_fullStr Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
title_full_unstemmed Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
title_short Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
title_sort decrease of pparδ in type 1 like diabetic rat for higher mortality after spinal cord injury
url http://dx.doi.org/10.1155/2014/456386
work_keys_str_mv AT chengchiatsai decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury
AT kungshinglee decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury
AT shenghsienchen decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury
AT lijenchen decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury
AT kengfanliu decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury
AT jueitangcheng decreaseofppardintype1likediabeticratforhighermortalityafterspinalcordinjury